Evidence map›Paper›PMID 40201700›Full record

ReviewFrontiers in pharmacology2025

Pharmacological mechanism and clinical application of ciprofol.

Jianshun Zhou, Lifeng Wang, Zhaoying Zhong, Lei Yuan, Jinhua Huang, Ping Zou, Xiaohui Cao, Donglan Peng, Baozhen Liao, Jianqiang Zeng

Abstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jianshun Zhou *Department of Anesthesiology, Ganzhou Cancer Hospital, Ganzhou, Jiangxi, China.
Lifeng Wang *Department of Anesthesiology, First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, China.
Zhaoying ZhongDepartment of Anesthesiology, Ganzhou Cancer Hospital, Ganzhou, Jiangxi, China.
Lei YuanDepartment of Anesthesiology, Ganzhou Cancer Hospital, Ganzhou, Jiangxi, China.
Jinhua HuangDepartment of Anesthesiology, Ganzhou Cancer Hospital, Ganzhou, Jiangxi, China.
Ping ZouDepartment of Anesthesiology, Ganzhou Cancer Hospital, Ganzhou, Jiangxi, China.
Xiaohui CaoDepartment of Anesthesiology, Ganzhou Cancer Hospital, Ganzhou, Jiangxi, China.
Donglan PengDepartment of Anesthesiology, Ganzhou Cancer Hospital, Ganzhou, Jiangxi, China.
Baozhen LiaoDepartment of Anesthesiology, Ganzhou Cancer Hospital, Ganzhou, Jiangxi, China.
Jianqiang ZengDepartment of Anesthesiology, Ganzhou Cancer Hospital, Ganzhou, Jiangxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Propofol has become one of the most commonly used anesthetic agents because of its good sedative effects, rapid onset, and fast metabolism. However, its associated respiratory and circulatory depression and injection pain make it difficult for patients to tolerate. Ciprofol, which is structurally similar to propofol but has an additional cyclopropyl group, is less likely to impact respiratory and circulatory function and cause injection pain, highlighting its potential for clinical application. Currently, as research on Ciprofol is still in the exploratory stage, its clinical application is limited because its underlying mechanisms are not yet fully understood. The aim of this article is to review the pharmacological mechanisms of propofol, hypothesize the primary pharmacological effects and potential adverse reactions of Ciprofol, and summarize its current clinical application status, with the goal of providing a reference for future clinical use.

Indexed as

anesthesiaciprofolGABApropofolsedation

Identifiers

PMID40201700
PMCPMC11975953

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.